SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients
Evan C. Ray(University of Pittsburgh), David Cassiman, Danica Novacic(National Institutes of Health), Cary R. Boyd‐Shiwarski(University of Pittsburgh), Pengfei Liu(Macau University of Science and Technology)
Cited by 51
Related Papers
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
The adverse role of endocrine disrupting chemicals in the reproductive system
|Frontiers in Endocrinology|2024|160
The natural history of classic galactosemia: lessons from the GalNet registry
|Orphanet Journal of Rare Diseases|2019|147